Article Dans Une Revue iScience Année : 2025

Divergent responses to SARS-CoV-2 infection in bronchial epithelium with pre-existing respiratory diseases

Résumé

Pre-existing respiratory diseases may influence coronavirus disease (COVID-19) susceptibility and severity. However, the molecular mechanisms underlying the airway epithelial response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection severity in patients with chronic respiratory diseases remain unelucidated. Using an in vitro model of differentiated primary bronchial epithelial cells, we aimed to investigate the molecular mechanisms of SARS-CoV-2 infection in pre-existing cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD). Our study revealed reduced susceptibility of CF and COPD airway epithelia to SARS-CoV-2, relative to that in healthy controls. Mechanistically, reduced transmembrane serine protease 2 (TMPRSS2) activity potentially contributed to this resistance of CF epithelium. Upregulated complement and inflammatory pathways in CF and COPD epithelia potentially primed the antiviral state prior to infection. Analysis of a COVID-19 patient cohort validated our findings, correlating specific inflammatory markers (IP-10, SERPINA1, and CFB) with COVID-19 severity. This study elucidates SARS-CoV-2 pathogenesis and identifies potential biomarkers for clinical monitoring.

Fichier principal
Vignette du fichier
PIIS2589004225002597.pdf (11.79 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04947599 , version 1 (14-02-2025)

Identifiants

Citer

Justine Oliva, Manon Ruffin, Claire Calmel, Aurélien Gibeaud, Andrés Pizzorno, et al.. Divergent responses to SARS-CoV-2 infection in bronchial epithelium with pre-existing respiratory diseases. iScience, 2025, pp.111999. ⟨10.1016/j.isci.2025.111999⟩. ⟨hal-04947599⟩
1312 Consultations
160 Téléchargements

Altmetric

Partager

  • More